QuidelOrtho Grants Stock Units to New CFO
QuidelOrtho announced it has granted 356,555 restricted stock units (RSUs) to its Chief Financial Officer, Micah Young, as an inducement award.
QuidelOrtho Corporation, a global provider of diagnostic solutions, announced on July 15, 2026, that it granted 356,555 restricted stock units (RSUs) to Micah Young, the company's Chief Financial Officer.
The grant was made under the company's 2026 Inducement Plan, which is used to attract new employees in accordance with Nasdaq Listing Rule 5635(c)(4). This rule allows companies to grant equity awards as an inducement to individuals entering into employment.
The RSUs were granted on July 15, 2026, and are set to vest in equal annual installments over the first three anniversaries of the grant date. Continued employment with QuidelOrtho through each vesting date is a condition for the RSUs to vest.
QuidelOrtho focuses on diagnostic solutions across clinical chemistry, immunoassay, immunohematology, and molecular testing. The company aims to improve patient outcomes by providing fast, accurate, and reliable diagnostic results.